| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |